Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties (Q37199637)

18 August 2017

1 reference

title

Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

Toni K Choueiri

1

1 reference

PubMed ID

18577983

18 August 2017

Derek Raghavan

series ordinal

2

1 reference

18 August 2017

24 June 2008

1 reference

Nature Clinical Practice Oncology

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

444-454

1 reference

18 August 2017

8

1 reference

Bladder cancer: results of radiation therapy in 384 patients

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

Bladder cancer: long-term follow-up results of patients treated with radical radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Progress in the chemotherapy of metastatic cancer of the urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

The radiation response of human bladder cancer assessed in vitro or as xenografts in immune-deprived mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Bladder carcinoma. Experience with radical and preoperative radiotherapy in 421 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Prognostic factors in patients with bladder carcinoma treated with definitive irradiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Assessment of factors influencing the outcome of radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Bladder carcinoma--a 20-year review of radical irradiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Integrated irradiation and cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Bladder cancer.Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Sensitizers and protectors in radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Long-term platinum excretion in patients treated with cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Selective bladder preservation by combination treatment of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Management of muscle invasive bladder cancer--British approaches to organ conservation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1159

7 January 2021

Identifiers

DOI

10.1038/NCPONC1159

1 reference

18 August 2017

1 reference

PubMed ID

18577983